249
Views
7
CrossRef citations to date
0
Altmetric
Articles

Regulation of inflammatory response of macrophages and induction of regulatory T cells by using retinoic acid-loaded nanostructured lipid carrier

, , , , , , & show all
Pages 1-11 | Received 29 May 2018, Accepted 24 Jun 2018, Published online: 17 Jan 2019

References

  • Erkelens MN, Mebius RE. Retinoic acid and immune homeostasis: a balancing act. Trends Immunol. 2017;38(3):168–180.
  • Raverdeau M, Mills KHG. Modulation of T cell and innate immune responses by retinoic acid. J Immunol. 2014;192:2953–2958.
  • Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685–698.
  • Pino-Lagos K, Benson MJ, Noelle RJ. Retinoic acid in the immune system. Ann N Y Acad Sci. 2008;1143:170–187.
  • Reifen R, Nur T, Ghebermeskel K, et al. Vitamin A deficiency exacerbates inflammation in a rat model of colitis through activation of nuclear factor-kappaB and collagen formation. J Nutr. 2002;132:2743–2747.
  • Bai A, Lu N, Guo Y, et al. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol. 2009;86:959–969.
  • Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol. 2009;21:281–285.
  • Hong K, Zhang Y, Guo Y, et al. All-trans retinoic acid attenuates experimental colitis through inhibition of NF-κB signaling. Immunol Lett. 2014;162:34–40.
  • Mielke LA, Jones SA, Raverdeau M, et al. Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med. 2013;210:1117–1124.
  • Kwok SK, Park MK, Cho ML, et al. Retinoic acid attenuates rheumatoid inflammation in mice. J Immunol. 2012;189:1062–1071.
  • Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling. Mucos Immunol. 2013;6:335–346.
  • Sakamoto H, Koya T, Tsukioka K, et al. The effects of all-trans retinoic acid on the induction of oral tolerance in a murine model of bronchial asthma. Int Arch Allergy Immunol. 2015;167:167–176.
  • Hondono K, Firdausi SN, Pratama MZ, et al. Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus. Clin Rheumatol. 2016;35:631–638.
  • Tan X, Meltzer N, Lindenbaums S. Determination of the kinetics of degradation of 13-cis-retinoic acid and all-trans-retinoic acid in solution. J Pharm Biomed Anal. 1993;11:817–822.
  • Szuts EZ, Harosi FI. Solubility of retinoids in water. Arch Biochem Biophys. 1991;287:297–304.
  • Achkar CC, Bentel JM, Boylan JF, et al. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice. Drug Metab Dispos. 1994;22:451–458.
  • Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59:522–530.
  • Liao X, Ren J, Wei CH, et al. Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model. PLoS One. 2015;10:e0118176.
  • Svilenov H, Tzachev C. In A. Seifalian, A.D. Mel, D.M. Kalaskar, editors. Solid Lipid Nanoparticle-A Promising Drug Delivery System. Cheshire: One Central Press; 2014. Vol. 8, p. 187–235.
  • Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm. 2008;34:1394–1405.
  • Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest. 2010;98:756–763.
  • Bellezzo JM, Leingang KA, Bulla GA, et al. Modulation of lipopolysaccharide-mediated activation in rat Kupffer cells by antioxidants. J Lab Clin Med. 1998;131:36–44.
  • Gasparini C, Feldmann M. NF-κB as a target for modulating inflammatory responses. Curr Pharm Des. 2012;18:5735–5745.
  • Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10:36–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.